Study confirms some cancer immunotherapies may lead to myocarditis and other potentially serious arrhythmias
Middlemen net more than half of insulin expenditures, study finds
5 November 2021NIH scientists identify mechanism that may influence infectivity of SARS-CoV-2 variants
5 November 2021Study confirms some cancer immunotherapies may lead to myocarditis and other potentially serious arrhythmias
Immune checkpoint inhibitors (ICIs) have transformed cancer care by unleashing T-cells to fight tumors, but they can cause serious cardiotoxicities including myocarditis. ICI-induced myocarditis represents a new clinical syndrome because of the novelty and considerable usage of ICIs.
